<?OLF?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dermatol Ther</journal-id><journal-id journal-id-type="iso-abbrev">Dermatol Ther</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1529-8019</journal-id><journal-id journal-id-type="publisher-id">DTH</journal-id><journal-title-group><journal-title>Dermatologic Therapy</journal-title></journal-title-group><issn pub-type="ppub">1396-0296</issn><issn pub-type="epub">1529-8019</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Inc.</publisher-name><publisher-loc>Hoboken, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1111/dth.13639</article-id><article-id pub-id-type="publisher-id">DTH13639</article-id><article-id pub-id-type="other">DTH-20-0628.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Immunosuppressive agents for dermatological indications in the ongoing <styled-content style="fixed-case" toggle="no">COVID</styled-content> 19 pandemic: rationalizing use and clinical applicability</article-title><alt-title alt-title-type="left-running-head">Khurana and Saxena</alt-title></title-group><contrib-group><contrib id="dth13639-cr-0001" contrib-type="author" corresp="yes"><name><surname>Khurana</surname><given-names>Ananta</given-names></name><degrees>MD, DNB, MNAMS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7020-7777</contrib-id><role>Associate Professor</role><xref ref-type="aff" rid="dth13639-aff-0001">
<sup>1</sup>
</xref><address><email>drananta2014@gmail.com</email></address></contrib><contrib id="dth13639-cr-0002" contrib-type="author"><name><surname>Saxena</surname><given-names>Snigdha</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9665-7853</contrib-id><role>Senior Resident</role><xref ref-type="aff" rid="dth13639-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="dth13639-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Dermatology</named-content>
<institution>Dr Ram Manohar Lohia Hospital and PGIMER</institution>
<city>New Delhi</city>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Email: <email>drananta2014@gmail.com</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>5</month><year>2020</year></pub-date><elocation-id>10.1111/dth.13639</elocation-id><history><date date-type="received"><day>28</day><month>4</month><year>2020</year></date><date date-type="rev-recd"><day>12</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>14</day><month>5</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> This article is protected by copyright. All rights reserved. <copyright-statement>--><copyright-statement content-type="article-copyright">This article is protected by copyright. All rights reserved.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DTH-9999-na.pdf"/><abstract><title>ABSTRACT</title><p>The ongoing COVID 19 epidemic has brought to the fore many concerns related to use of immunosuppressive agents (ISAs) in dermatology. While it is unclear whether the patients on ISAs for skin conditions are more prone to develop COVID 19, and what impact the ISA may have on the clinical outcome if a patient <italic>does</italic> get infected, rationalizations based on the specific immune effects of each drug, and existing literature on incidence of various infections with each, are possible. In this review, we provide the readers with practically useful insights into these aspects, related to the conventional ISAs, and briefly mention the clinical outcome data available on related scenarios from other patient groups so far. In the end, we have attempted to provide some clinically useful points regarding practical use of each dermatologically relevant conventional ISA in the current scenario.</p><p>This article is protected by copyright. All rights reserved.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="dth13639-kwd-0001">COVID&#x02010;19</kwd><kwd id="dth13639-kwd-0002">dermatology</kwd><kwd id="dth13639-kwd-0003">immunosuppressive</kwd><kwd id="dth13639-kwd-0004">steroids</kwd><kwd id="dth13639-kwd-0005">methotrexate</kwd><kwd id="dth13639-kwd-0006">azathioprine</kwd><kwd id="dth13639-kwd-0007">cyclophosphamide</kwd><kwd id="dth13639-kwd-0008">mycophenolate</kwd><kwd id="dth13639-kwd-0009">ciclosporine</kwd><kwd id="dth13639-kwd-0010">pathogenesis</kwd><kwd id="dth13639-kwd-0011">immunology</kwd></kwd-group><counts><fig-count count="0"/><table-count count="2"/><page-count count="1"/><word-count count="300"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>accepted-manuscript</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:09.06.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="dth13639-ntgp-0001"><fn id="dth13639-note-0001"><p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/dth.13639.</p></fn></fn-group></notes></front></article>